approveluxturna.ca valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: * Disallow: /wordpress/wp-admin/ Allow: /wordpress/wp-admin/admin-ajax.php Sitemap:
Meta Tags
Title Approve
Description Home Skip to the content Search Approve Luxturna Menu Home About Luxturna Drug Approval Process in Canada SEND AN EMAIL Search Search for: Close search Close M
Keywords N/A
Server Information
WebSite approveluxturna faviconapproveluxturna.ca
Host IP 216.70.102.175
Location United States
Related Websites
Site Rank
More to Explore
approveluxturna.ca Valuation
US$486,509
Last updated: 2023-05-11 22:36:38

approveluxturna.ca has Semrush global rank of 21,755,646. approveluxturna.ca has an estimated worth of US$ 486,509, based on its estimated Ads revenue. approveluxturna.ca receives approximately 56,136 unique visitors each day. Its web server is located in United States, with IP address 216.70.102.175. According to SiteAdvisor, approveluxturna.ca is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$486,509
Daily Ads Revenue US$450
Monthly Ads Revenue US$13,473
Yearly Ads Revenue US$161,671
Daily Unique Visitors 3,743
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
approveluxturna.ca. A 43200 IP: 216.70.102.175
approveluxturna.ca. NS 43200 NS Record: ns2.mediatemple.net.
approveluxturna.ca. NS 43200 NS Record: ns1.mediatemple.net.
approveluxturna.ca. MX 43200 MX Record: 10 mail.approveluxturna.ca.
HtmlToTextCheckTime:2023-05-11 22:36:38
Skip to the content Search Approve Luxturna Menu Home About Luxturna Drug Approval Process in Canada SEND AN EMAIL Search Search for: Close search Close Menu Home About Luxturna Drug Approval Process in Canada SEND AN EMAIL Home Scroll Down NEW – CTV News story on an 11 year old boy’s story of going blind and how Luxturna can save his sight. Luxturna is the world’s first approved targeted gene therapy for a blinding eye disease. It can restore night vision and stop blindness. Luxturna was approved by Health Canada in October 2020 as a treatment. Bureaucratic delays to provide access to Luxturna have created a 2-tier health care in Canada. As of February 2023, only four provinces have agreed to publicly fund Luxturna, putting this ground breaking treatment out of reach for Canadians who have been on the waiting list for over three years. During this time they have been experiencing irreversible vision loss. TIME = SIGHT and we can not let a bureaucratic process slow down access to
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: nginx
Date: Wed, 17 Nov 2021 09:21:23 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Powered-By: PHP/7.0.33
X-Redirect-By: WordPress
Location: https://approveluxturna.ca/

HTTP/2 200 
server: nginx
date: Wed, 17 Nov 2021 09:21:23 GMT
content-type: text/html; charset=UTF-8
x-powered-by: PHP/7.0.33
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
approveluxturna.ca Whois Information
Domain Name: approveluxturna.ca
Registry Domain ID: 81450356-CIRA
Registrar WHOIS Server: whois.ca.fury.ca
Registrar URL: ca.godaddy.com
Updated Date: 2020-06-19T15:00:51Z
Creation Date: 2020-04-20T14:56:30Z
Registry Expiry Date: 2022-04-20T14:56:30Z
Registrar: Go Daddy Domains Canada, Inc
Registrar IANA ID: not applicable
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: ns1.mediatemple.net
Name Server: ns2.mediatemple.net
DNSSEC: unsigned
>>> Last update of WHOIS database: 2021-11-17T09:14:00Z <<<